Scientist identify enzyme linked to poor survival rate in leukemia patients
High levels of this enzyme, indoleamine 2,3 dioxygenase, or IDO, at diagnosis can also identify those who might benefit most by taking an IDO inhibitor along with their standard therapy
Nov 27, 2017, 17:28 PM IST